Short answer
Danaher Corporation (DHR) filed an 8-K current report with the SEC on October 13, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 8.01 (Other Events). Board expanded to 13 members with immediate appointments of former CFO Daniel Comas and biotech executive Robert Hershberg.
Danaher Corporation 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Board expanded to 13 members with immediate appointments of former CFO Daniel Comas and biotech executive Robert Hershberg
- Comas brings Danaher finance, treasury, risk management and corporate development experience, strengthening board-level financial oversight
- Hershberg joins the Science and Technology Committee, adding pharmaceutical and biotechnology expertise
- Comas’s consulting agreement terminated September 30, 2026, after compensation of $525,000 in 2025 and $393,750 in 2026
- Alan Spoon will retire at the 2027 annual meeting, without disagreement with Danaher, creating one board turnover event
Item 8.01 · Other Events
- Steven and Mitchell Rales waived Founder RSUs covering 500,000 shares each, reducing potential equity dilution
- Waivers received no consideration, eliminating the associated share-based compensation benefit
- Founder equity awards remain subject to separate stock-option awards disclosed previously
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Danaher Corporation 8-K filings
Get the next DHR 8-K as it lands
Follow DHR for push alerts, or ask the research agent what this filing means.